Unveiling the Synergistic Potential: Bispecific Antibodies in Conjunction with Chemotherapy for Advanced Non-Small-Cell Lung Cancer Treatment

Lung cancer remains the leading cause of cancer-related mortality worldwide, with non-small-cell lung cancer (NSCLC) accounting for the majority of the cases. Despite advancements in targeted therapies and immunotherapies, many patients still rely on chemotherapy, highlighting the need for innovativ...

Full description

Bibliographic Details
Published in:Current Oncology
Main Authors: Saqib Raza Khan, Daniel Breadner
Format: Article
Language:English
Published: MDPI AG 2025-03-01
Subjects:
lung cancer
bispecific antibodies
chemotherapy
tumor microenvironment
Online Access:https://www.mdpi.com/1718-7729/32/4/206

Internet

https://www.mdpi.com/1718-7729/32/4/206

Similar Items